Insights

Growing Financial Base With a substantial funding of 1.3 billion dollars and annual revenues between 100 and 250 million dollars, Blueprint Medicines demonstrates strong financial health, indicating potential for expanding sales efforts, especially in new drug development and clinical trial services.

Acquisition Momentum Sanofi’s recent acquisition of Blueprint Medicines for nearly 9.5 billion dollars highlights a significant emphasis on immunology and oncology therapeutics, presenting sales opportunities for suppliers or partners in drug manufacturing, research collaborations, and commercialization support.

Innovative Pipeline Blueprint’s broad pipeline of early-stage to advanced clinical programs in allergy, inflammation, and cancer offers opportunities for medical device companies, laboratory services, and strategic partnerships focused on supporting clinical trials and diagnostic development.

Market Leadership Participation in key healthcare conferences and a focus on groundbreaking therapies like Ayvakit reflect their status as a leader in niche biopharmaceutical markets, indicating demand for innovative solutions and services in rare disease research, patient data management, and specialty logistics.

Technological Adoption Utilization of cloud services like Cloudflare, Salesforce, and SAP signals a tech-forward approach, opening potential sales avenues for IT infrastructure, cloud security, and enterprise software solutions tailored to biotech and pharmaceutical companies seeking operational efficiency.

Blueprint Medicines Tech Stack

Blueprint Medicines uses 8 technology products and services including Cloudflare, Salesforce, SAP, and more. Explore Blueprint Medicines's tech stack below.

  • Cloudflare
    Content Management System
  • Salesforce
    Customer Relationship Management
  • SAP
    Customer Relationship Management
  • Microsoft Intune
    Enterprise Mobility Management
  • PWA
    Miscellaneous
  • macOS
    Operating Systems & Computing Languages
  • Pantheon
    Platform As A Service
  • PHP
    Programming Languages

Media & News

Blueprint Medicines's Email Address Formats

Blueprint Medicines uses at least 1 format(s):
Blueprint Medicines Email FormatsExamplePercentage
FLast@blueprintmedicines.comJDoe@blueprintmedicines.com
91%
First.Last@blueprintmedicines.comJohn.Doe@blueprintmedicines.com
8%
FL@blueprintmedicines.comJD@blueprintmedicines.com
1%

Frequently Asked Questions

What is Blueprint Medicines's phone number?

Minus sign iconPlus sign icon
You can contact Blueprint Medicines's main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Blueprint Medicines's stock symbol?

Minus sign iconPlus sign icon
Blueprint Medicines is a publicly traded company; the company's stock symbol is BPMC.

What is Blueprint Medicines's official website and social media links?

Minus sign iconPlus sign icon
Blueprint Medicines's official website is blueprintmedicines.com and has social profiles on LinkedInCrunchbase.

What is Blueprint Medicines's SIC code NAICS code?

Minus sign iconPlus sign icon
Blueprint Medicines's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Blueprint Medicines have currently?

Minus sign iconPlus sign icon
As of December 2025, Blueprint Medicines has approximately 782 employees across 4 continents, including North AmericaEuropeAsia. Key team members include Chief Medical Officer: B. H.Chief People Officer: D. D.Chief Business Officer: S. S.. Explore Blueprint Medicines's employee directory with LeadIQ.

What industry does Blueprint Medicines belong to?

Minus sign iconPlus sign icon
Blueprint Medicines operates in the Biotechnology Research industry.

What technology does Blueprint Medicines use?

Minus sign iconPlus sign icon
Blueprint Medicines's tech stack includes CloudflareSalesforceSAPMicrosoft IntunePWAmacOSPantheonPHP.

What is Blueprint Medicines's email format?

Minus sign iconPlus sign icon
Blueprint Medicines's email format typically follows the pattern of FLast@blueprintmedicines.com. Find more Blueprint Medicines email formats with LeadIQ.

How much funding has Blueprint Medicines raised to date?

Minus sign iconPlus sign icon
As of December 2025, Blueprint Medicines has raised $1.3B in funding. The last funding round occurred on Jun 30, 2022 for $1.3B.

When was Blueprint Medicines founded?

Minus sign iconPlus sign icon
Blueprint Medicines was founded in 2011.

Blueprint Medicines

Biotechnology ResearchMassachusetts, United States501-1000 Employees

Blueprint Medicines, a Sanofi company, is a fully integrated global biopharmaceutical company that invents life-changing medicines. We seek to alleviate human suffering by solving important medical problems in two core focus areas: allergy/inflammation and oncology/hematology. Our approach begins by targeting the root causes of disease, using deep scientific knowledge in our core focus areas and drug discovery expertise across multiple therapeutic modalities. We have a proven track record of success with two approved medicines in the U.S. and Europe. Leveraging our established research, development, and commercial capability and infrastructure, we now aim to significantly scale our impact by advancing a broad pipeline of programs ranging from early science to advanced clinical trials in mast cell diseases including systemic mastocytosis and chronic urticaria, breast cancer and other solid tumors.

Patients are at the center of our mission. We know that in order to make a difference in their lives, we must create an environment where our employees — also known as the Blue Crew — can do their best work. Our culture of transparency, curiosity and diversity empowers us to draw upon a wide range of backgrounds and perspectives to build a conscientious team dynamic. Ideas come from every member of the Blue Crew, from the executive team to new hires. Each day, our teams commit to approach one another with respect and trust: a simple promise that fosters an inclusive and collaborative spirit.

We care deeply about the communities where we live and work, and we strive to make a profound impact where it matters most. Learn more about who we are and explore our career opportunities at https://www.blueprintmedicines.com/careers/. 

Read our community guidelines: https://www.blueprintmedicines.com/community-guidelines/.

Section iconCompany Overview

Phone number
SIC Code
8733 - Noncommercial Research Organizations
Stock Symbol
BPMC
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2011
Employees
501-1000

Section iconFunding & Financials

  • $1.3B

    Blueprint Medicines has raised a total of $1.3B of funding over 9 rounds. Their latest funding round was raised on Jun 30, 2022 in the amount of $1.3B.

  • $100M$250M

    Blueprint Medicines's revenue is estimated to be in the range of $100M$250M

Section iconFunding & Financials

  • $1.3B

    Blueprint Medicines has raised a total of $1.3B of funding over 9 rounds. Their latest funding round was raised on Jun 30, 2022 in the amount of $1.3B.

  • $100M$250M

    Blueprint Medicines's revenue is estimated to be in the range of $100M$250M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.